Composite tablets of human recombinant bone morphogenetic protein 2 (rhBMP-2) and poly-(D,L)-lactide (PDLLA) (1-2 mg rhBMP-2/g PDLLA) were prepared by foaming of PDLLA with supercritical CO 2 . Release kinetics of rhBMP-2 were measured by a continuous flow and a batch dilution method at 22 °C and 50 °C respectively. In both cases a two-phase first-order release was found. Release half-lives of the sustained release phases (87-90% of total) decreased significantly from 348 days at 22 °C to 86 days at 55 °C i.e. by a factor of 4 indicating a coupling with PDLLA hydrolysis. The released rhBMP-2 was biologically active.
Introduction
In the preparation of bioactive implant materials either by the adsorption or encapsulation of protein growth factors a bioadapted drug delivery is one of the major objectives. Release kinetics of a substance from a polymer substrate can be described by the following equation (see ref. [1] ): 1 2 [
where k 1 and k 2 are the rate constants of dissociation and association (i.e. readsorption) respectively.
[], [PLA)] and [•PLA] denote the concentration of protein, polylactic acid and the protein-polylactic acid complex respectively. Under the condition that the system is far from equilibrium, the second term (readsorption) becomes zero and eq. 1 reduces to a first order reaction, which on integration yields the exponential equation:
where C = [•PLA] 0 i.e. the initial concentration of the protein-polylactic acid complex at time zero. First-order kinetics have also been shown for the degradation of the polymers poly(lactic-co-glycolic acid) (PLGA) [2] and PLA [3] . If the protein is released into a reservoir within the polymer and its diffusion to the bulk is restricted by pores, then linear zero-order kinetics are observed [4] . The major techniques for eliminating readsorption are dilution [1, 5] and release under continuous flow conditions as will be shown below. As a model system 125 I-rhBMP-2 incorporated into PDLLA tablets by foaming with supercritical CO 2 (scCO 2 ) [6] will be employed.
Methods
Self-prepared rhBMP-2 [7, 8] (activity equivalent: K 0.5~5 -20 nM [8, 9] ) was employed and labelled with 125 IrhBMP-2 [7] . 1 g defined PDLLA granules with CaCO 3 was suspended in 1.6 ml 125 I-BMP-2 solution and intensely homogenized [6] . During the mixing procedure a slurry formed which was lyophilized to a powder and fluidized in teflon molds (10 x 5 x 2 mm openings) for 16 h at 45 °C and 100 bar, depressurization 1-2 min, yielding composite tablets 10 x 5 x 2 mm, weight: ~38 mg, vol. ~0.106 cm 3 . In method 1 (continuous flow) the tablets were placed in a flow cell (Fig. 1) at room temperature (~ 22 °C). To wash out released protein, cells were perfused with PBS (pH 7.4) at a flow-rate of ca. 10 mL/h by a multiple channel peristaltic pump (205 S, Fa. Watson-Marlow, Willmington, USA) for 40 days. At specified times, the flow cell with the tablet, was measured in a -counter. After the experiments the empty flow cells were corrected for nonspecifically adsorbed 125 I-rhBMP-2 during release. Nonspecifically retained rhBMP-2 comprised ca 6-7% of the released 125 I-rhBMP-2. In method 2 (batch dilution) 125 IrhBMP-2 was released from the 125 I-rhBMP-2/PDLLA tablets into 1.5 mL PBS-buffer (pH 7.4) in vials on a in a heated shaker at 50 °C for 40 days. At the indicated times the tablets were washed two times with 1.5 mL fresh PBS, resuspended in 1.5 mL and counted in a -counter. Curves were fitted by the PC program Prism 4 for Windows [8] . Calculated half-lives were corrected for the spontaneous decay of 125 I (t 1/2 =60d). Fig. 3 show the double exponential decay of 125 IrhBMP-2 /PDLLA tablets at 22 °C and 50 °C respecttively. The derived rate constants are shown in Table 1 together with half-lives of the burst and the sustained release phases. The decay rate increases 4-fold at 50 °C. There was no indication of a significant readsorption. . 3 ) were placed in the chamber (1.5 ml) and perfused with buffer at 22°C, at a flow rate of 10 mL/h); mean ± SD, n = 3. For constants see Table 1 . The data was fitted to a 2-phase exponential function. Tablets were placed in 1.5 mL vials in a heated shaker at 50 °C. At given time points tablets were washed twice and resuspended in fresh 1.5 mL buffer. mean ± SD, n = 3. For constants see Table 1 . 
Results

Fig. 2 and
Discussion
The experiments demonstrate first-order release kinetics of rhBMP-2 from foamed PDLLA tablets in agreement with PLA hydrolysis [3] . A temperature increase form 22 °C to 50 °C increases the dissolution rate of 125 I-rhBMP-2/PDLLA tablets (possibly by PDLLA hydrolysis) by a factor of 4.
